SCHEMBL18792145

SCHEMBL18792145

Cc1ccc(CC(C)NO)c2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.45
▸ SLC6A4 P31645 2/20 0.41
▸ ADRB2 P07550 6/20 0.38
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ DAO P14920 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ APAF1 O14727 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CYP2A6 P11509 1/20 0.35
▸ SIGMAR1 Q99720 1/20 0.35
▸ NR3C1 P04150 1/20 0.35
▸ PGR P06401 1/20 0.35
▸ NR3C2 P08235 1/20 0.35
▸ XIAP P98170 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7832116 0.80 CYP1A2 (0.54) CYP1A2SLC6A4CYP3A4CYP2D6CYP2C19
SCHEMBL18792143 0.79 ADRB2 (0.39) CYP1A2ADRB2CYP3A4CYP2D6ALOX15
SCHEMBL18769889 0.76 CYP1A2 (0.35) CYP1A2ADRB2DAOL3MBTL1NR3C1
SCHEMBL18769849 0.76 ADRB2 (0.56) ADRB2
SCHEMBL18769851 0.76 SIGMAR1 (0.46) SLC6A4ADRB2CYP3A4CYP2D6POLB
SCHEMBL18769857 0.74 OPRK1 (0.56) CYP1A2SLC6A4ADRB2CYP3A4CYP2D6
SCHEMBL18769831 0.73 ADRB2 (0.58) SLC6A4ADRB2CYP3A4CYP2D6
SCHEMBL30975074 0.73 CYP1A2 (0.62) CYP1A2CYP3A4CYP2D6CYP2C19DAO
SCHEMBL9519292 0.73 CYP1A2 (0.62) CYP1A2CYP3A4CYP2D6CYP2C19DAO
SCHEMBL31532953 0.71 CYP1A2 (0.59) CYP1A2CYP3A4CYP2D6CYP2C19DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017070052-A1 COMPOSITIONS AND METHODS OF REGULATING CANCER RELATED DISORDERS AND DISEASES ONCO THERAPIES LLC (US) 2017-04-27 — — WO disclosed
Send feedback